The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

The critical key to weight loss success? Sustainability. No single diet or plan works for everybody, but a secret formula does exist – and it’s unique to you.

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to ...

In the U.S., the least active 25% of the population over 40 could add 11 years to their average life expectancy if they were ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

Adding just five minutes of activity a day could lower systolic blood pressure (the top number in a blood pressure reading) ...

With your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

Older adults who reported excessive daytime sleepiness and a lack of enthusiasm were more likely to develop a condition that ...

People whose choice of alcoholic beverage is exclusively beer tend to have particularly poor diets. They also are more likely ...

The FDA has approved an antibiotic called minocycline for the treatment of rosacea in adults. The drug, which is taken orally ...